Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -4.368% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a O=C(c1cccc(F)c1)N1CCCC(C(=O)N2CCCCC2)C1
b O=C(O/N=C/c1cccc([N+](=O)[O-])c1)C1CC1
c O=C1NC2(CCCC2)C(=O)N1CC(=O)N(Cc1ccccc1)c1ccccc1
Answer: c. O=C1NC2(CCCC2)C(=O)N1CC(=O)N(Cc1ccccc1)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1NC2(CCCC2)C(=O)N1CC(=O)N(Cc1ccccc1)c1ccccc1
O=C1NC2(CCCC2)C(=O)N1CC(=O)N(Cc1ccccc1)c1ccccc1
N-benzyl-2-(2,4-dioxo-1,3-diazaspiro[4.4]nonan-3-yl)-N-phenylacetamide